Biotest Pharmaceuticals Corporation (BPC), a leading developer of immunology biotherapeutic products, is pleased to announce the addition of its newest plasma collection center located at 311 North Patterson Road, in Valdosta, Georgia. The almost 16,000 square foot state-of-the-art facility officially opened its doors for business on June 30th 2014 and brings the total number of BPC's plasma collection centers to sixteen.
"This Center is the second facility we've opened in 2014, reinforcing our continued commitment in the expansion of our existing network of centers to better serve the thousands of patients that rely on plasma based therapies," said Jordan Siegel, BPC's Chief Executive Officer.
The plasma donated at Biotest Plasma Centers is used to manufacture critical care therapies that treat life threatening disorders in a variety of therapeutic areas, such as BPC's BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] and Nabi-HB® [Hepatitis B Immune Globulin (Human)].
BPC has invested approximately $2.0 million in construction of this facility. The Company expects to add over fifty jobs to Valdosta's local economy and currently has employment opportunities available for medical personnel and phlebotomists.
In addition to supporting the local economy through employment opportunities, the plasma center is actively recruiting local residents to donate plasma. Plasma donors not only contribute the source material for these plasma derived therapies that save the lives of thousands of patients but also are compensated for their donations.
Distinct immune profiles linked to adverse reactions from immunotherapy